To balance immunity and tolerance, the endogenous pool of Foxp3 + regulatory T (T reg ) cells is tightly controlled, but the underlying mechanisms of this control remain poorly understood. Here we show that the number of T reg cells is negatively regulated by the kinase Lkb1 in dendritic cells (DCs). Conditional knockout of the Lkb1 gene in DCs leads to excessive T reg cell expansion in multiple organs and dampens antigen-specific T cell immunity. Lkb1-deficient DCs are capable of enhancing, compared with wild-type DCs, T reg cell proliferation via cell-cell contact involving the IKK/IKBα-independent activation of the NF-κB/OX40L pathway. Intriguingly, treating wild-type mice with lipopolysaccharide selectively depletes Lkb1 protein in DCs, resulting in T reg cell expansion and suppressed inflammatory injury upon subsequent challenge. Loss of Lkb1 does not obviously upregulate proinflammatory molecules expression on DCs. We thus identify Lkb1 as a regulatory switch in DCs for controlling T reg cell homeostasis, immune response and tolerance.
F oxp3 + T reg cells, either derived from the thymus (natural T reg cells, nT reg cells) or induced from conventional T (T con ) cells in the periphery (induced T reg cells, iT reg cells), play pivotal roles in suppressing immune responses 1, 2 . Under steadystate conditions, the number of T reg cells in each organ is maintained at a constant threshold level to ensure self-tolerance while allowing the efficient initiation of defensive responses 2 . During a variety of inflammatory processes, T reg cells usually increase in number through proliferation or de novo generation, and this increase might serve as critical negative feedback to restrain inflammatory injuries 1, 3, 4 . However, despite the earlier recognition of IL-2 produced by effector T cells as a basic factor in the maintenance of the T reg cell pool 1,2 , our knowledge of how the number of T reg cells is specifically regulated in a wide range of tissues and under various immune conditions is still very limited.
Originally known as sentinels of the immune system required for initiating defensive responses, DCs critically maintain immune homeostasis not only through suppressing the activation or inducing the unresponsiveness/apoptosis of self-reactive T cells but also by promoting the generation, maintenance and/or expansion of T reg cells [5] [6] [7] . It is widely accepted that DCs can induce the de novo generation of iT reg cells via mechanisms dependent on antigen presentation to induce a distinct T cell receptor (TCR) signal 8 , costimulation via B7-CTLA4 9 or BTLA-HVEM 10 ligation, and TGF-β 11 and retinoic acid [12] [13] [14] production. Nevertheless, how DCs maintain or expand the existing pool of T reg cells to balance immunity and tolerance in vivo is unclear.
Liver kinase B1 (Lkb1) is a serine-threonine kinase that was first identified as a tumour suppressor whose mutation is responsible for Peutz Jeghers syndrome 15, 16 . Previous studies have highlighted a prominent role played by Lkb1 in the immune system; Lkb1 has been identified as a critical regulator of T cell development, activation, and metabolism 17 . Our recent work indicates that Lkb1 epigenetically stabilizes Foxp3 expression and promotes suppressive functions in T reg cells 18 . Lkb1 also inhibits the activation and inflammatory functions of innate macrophages 19 . However, the specific role played by Lkb1 in DCs, which are central to immune regulation, has not yet been studied.
In this study, using mice with the Lkb1 gene conditionally deleted in DCs, we find that the expression of Lkb1 is a feedforward factor in DCs rather than other immune cell types, required for restraining the steady-state T reg cell numbers in multiple organs, thereby allowing the efficient initiation of antigen-specific immune responses. We further evaluate whether ectopic Lkb1 downregulation in DCs contributes to increases in the T reg cell population during inflammatory processes. Indeed, we find that after challenging wild-type (WT) mice with Escherichia coli (E. coli)-derived lipopolysaccharide (LPS), Lkb1 protein is selectively depleted in DCs in a negative-feedback manner, resulting in the expansion of T reg cells that is necessary for protecting the host from inflammatory injury responses induced by lethal rechallenge doses. Mechanistically, the loss of Lkb1 activates a regulatory transcriptional programme in DCs, including the upregulation of Ox40l gene expression, to stimulate T reg cell proliferation. Thus, we provide data indicating that the homeostasis of T reg cells and the strength of immunosuppression are dynamically controlled by an Lkb1 regulatory switch in DCs, in a feedback manner, to ensure immune equivalence.
Results

Lkb1 deletion in DCs leads to T reg pool enlargement.
To investigate the role of Lkb1 in DCs, we generated a line of mice with Lkb1 conditionally deleted in DCs by crossing Cd11c Cre mice with Lkb1 f/f mice. We analysed the phenotype of DCs in the spleen and lymph nodes (LNs). No significant differences in the population size or cell surface expression of activation markers, including major histocompatibility complex (MHC) class II molecules and co-stimulatory molecules CD80 and CD86, were observed between DCs from Lkb1 f/f and Cd11c Cre Lkb1 f/f mice ( Supplementary Fig. 1a-c) , indicating that Lkb1 has little effect on DC maintenance and activation.
Since the major functions of DCs are to preserve steady-state T cell homeostasis and induce foreign antigen-specific T cell responses 20 , we sought to determine the phenotypical and functional alterations in T cells from Lkb1 f/f and Cd11c Cre Lkb1 f/f mice. Cd11c Cre Lkb1 f/f mice had higher percentages of CD4 + Foxp3 -and CD8 + Foxp3 -T cells that exhibited a CD44 hi CD62L lo effector/ memory phenotype ( Supplementary Fig. 2a) . However, despite a slight elevation in IL-2 and IL-17 production, the IL-4 and IFN-γ levels were not significantly increased in CD4 + Foxp3 -or CD8 + Foxp3 -T cells from Cd11c Cre Lkb1 f/f mice ( Supplementary  Fig. 2b ), indicating that excessive effector T cell differentiation was not present in Cd11c Cre Lkb1 f/f mice. Indeed, the Cd11c Cre Lkb1 f/f mice exhibited a normal body weight ( Supplementary Fig. 2c ) and did not display any signs of autoimmunity ( Supplementary Fig. 2d ). These results indicate that Cd11c Cre Lkb1 f/f mice are devoid of autoimmune diseases, even in the presence of a slightly activated T cell phenotype. Surprisingly, there were no significant differences in the proliferation of CFSE-labelled CD4 + and CD8 + T cells sorted from OT-II and OT-I transgenic mice after being co-cultured with Lkb1 f/f and Cd11c Cre Lkb1 f/f DCs loaded with the respective antigenic peptide in vitro ( Supplementary Fig. 2e ), suggesting that Lkb1 does not affect the DC function of priming antigen-specific T cell responses.
Strikingly, the percentage and absolute number of Foxp3 + T reg cells were greatly increased in the spleen and LNs from Cd11c Cre Lkb1 f/f mice compared with those from Lkb1 f/f mice, as was the expression of Ki67, an indicator of cell proliferation ( Fig. 1a-d) . However, no significant difference in the apoptosis of T reg cells from Lkb1 f/f mice and Cd11c Cre Lkb1 f/f was observed ( Supplementary Fig. 3a, b ). There were also significantly higher frequencies of T reg cells in peripheral non-lymphoid organs, including the blood, bone marrow (BM), lungs, liver, kidneys and brain, from Cd11c Cre Lkb1 f/f mice than in those from Lkb1 f/f mice (Fig. 1e, f) . However, the T reg cell frequency was not significantly elevated in the thymus in Cd11c Cre Lkb1 f/f mice ( Supplementary  Fig. 3c, d) , suggesting that the enlarged T reg cell compartment in the periphery was not caused by developmental dysregulation in the thymus. T reg cells from Cd11c Cre Lkb1 f/f mice displayed a CD44 hi CD62L lo activated phenotype and expressed higher levels of activation markers CD73 and ICOS (Fig. 1g ). In addition, T reg cells from Cd11c Cre Lkb1 f/f mice expressed high levels of Nrp1 and Helios [21] [22] [23] , which are characteristic markers of nT reg cells (Fig. 1g) , suggesting that these expanded T reg cells were mainly derived from the thymus rather than T con cells in the periphery. Thus, the Lkb1 deficiency in DCs caused strong T reg cell expansion in the periphery. However, Lkb1 seemed not to directly affect the suppressor function of T reg cells, since there was no difference in the suppressive capacity of T reg cells from Lkb1 f/f and Cd11c Cre Lkb1 f/f mice (Fig. 1h) .
Cd11c Cre Lkb1 f/f mice lack Lkb1 in all cells expressing CD11c, which include DCs and macrophages. To determine whether Lkb1-deficient macrophages contribute to the phenotype of the mice, we examined T reg and T con cells in the spleen and LNs of Lkb1 f/f and LysM Cre Lkb1 f/f mice, which carry the specific deletion of Lkb1 in myeloid-derived cells, including macrophages. We found that the Lkb1 deficiency in macrophages did not affect the percentages of T reg cells or the activation of CD4 + Foxp3 − and CD8 + Foxp3 − T cells ( Supplementary Fig. 4a-d) . These results further confirm that expansion of the T reg compartment was mainly caused by the deletion of Lkb1 in DCs.
Impaired immune responses due to increased T reg cell number. T reg cells play a predominant role in suppressing immune responses in vivo. We next determined the impact of the increased T reg cell number on antigen-specific T cell responses using an experimental autoimmune encephalomyelitis (EAE) mouse model. We observed lower clinical scores, reflecting less severe EAE, in Cd11c Cre Lkb1 f/f mice than in WT littermates (Fig. 2a) . It is well known that EAE is mediated by encephalitogenic Th1 and Th17 cells, which produce proinflammatory cytokines IFN-γ and IL-17, respectively 24 . Thus, we analysed the populations of CD4 + IFN-γ + T (Th1) and CD4 + IL-17 + T (Th17) cells in the spleen and brain. In Cd11c Cre Lkb1 f/f mice, the Th1 cell populations, but not the Th17 populations, were significantly decreased in the spleen and brain (Fig. 2b, c) . The levels of IL-17-producing T cells were slightly increased in Cd11c Cre Lkb1 f/f mice under steady-state conditions ( Supplementary Fig. 2b ), which indicates that Lkb1-deficient DCs might intrinsically have an increased capacity for stimulating Th17 differentiation. There was no difference in the extent of Th17 cell development between the Lkb1 f/f and Cd11c Cre Lkb1 f/f mice in the EAE model, suggesting that enhanced Th17 differentiation might in some manner counteract the enhanced suppressor function of the expanded T reg population. However, significantly reduced Th1 cell development and EAE disease severity were observed in Cd11c Cre Lkb1 f/f mice, indicating that the expanded T reg cell population dominated and resulted in overall alleviation of the immune response. As Lkb1 deficiency barely affected the antigen-specific T cell priming function of DCs ( Supplementary Fig. 2e ), we speculated that the impaired Th1 response was most likely due to enhanced immune suppression mediated by the enlarged T reg cell compartment in Cd11c Cre Lkb1 f/f mice. To further confirm the impact of increased T reg cell populations on antigen-specific T cell responses, we bred Foxp3 DTR mice to generate Lkb1 f/f Foxp3 DTR and Cd11c Cre Lkb1 f/ f Foxp3 DTR mice, in which Foxp3 + T reg cells could be specifically depleted with diphtheria toxin (DT) treatment (short-term DT treatment only resulted in a transient reduction in the T reg cell populations and did not lead to overt disease phenotypes or death in mice) 25 , and we conducted an in vivo assay of OVA antigeninduced T cell priming. Two days after DT treatment (Supplementary Fig. 5a ), we adoptively transferred CFSE-labelled CD4 + T cells from OT-II transgenic mice into DT-treated Lkb1 f/f , Cd11c Cre Lkb1 f/f , Lkb1 f/f Foxp3 DTR and Cd11c Cre Lkb1 f/f Foxp3 DTR mice via a tail vein injection, and we then challenged these mice with indicated doses of OVA to induce an antigen-specific T cell response. Lower percentages and numbers of proliferating OT-II T cells were detected in Cd11c Cre Lkb1 f/f mice than in Lkb1 f/f mice, while OT-II T cells in Cd11c Cre Lkb1 f/f Foxp3 DTR mice treated with DT exhibited stronger proliferation and higher absolute numbers than OT-II T cells in Cd11c Cre Lkb1 f/f mice ( Fig. 2d-f ). In addition, the production of IFN-γ in OT-II cells was negatively correlated with the proportion of T reg cells in vivo (Fig. 2g, h ). These data suggest that the impaired T cell response in the Cd11c Cre Lkb1 f/f mice was due to the expanded T reg cell compartment.
Lkb1-deficient DCs promote T reg cell proliferation. Although IL-2 plays a role in promoting T reg cell proliferation, the increased production of IL-2 in CD4 + Foxp3 − T cells in Cd11c Cre Lkb1 f/f mice was slight ( Supplementary Fig. 2b ) and could not explain the extremely high proportion of T reg cells among CD4 + T cells. Supplementary Fig. 5b ). The T reg cells displayed markedly increased proliferation and higher numbers of CD4 + Foxp3 + cells when co-cultured with Lkb1-deficient DCs than when co-cultured with WT DCs (Fig. 3a-c) .
We also confirmed this result with T reg cells (CD4 + YFP + ) from Foxp3 YFP-Cre mice ( Supplementary Fig. 5c -e). Next, we established a mixed BM chimaera mouse model to acquire WT and Lkb1-deficient DCs from the same environment. After coculturing these cells with CFSE-labelled T reg cells in the presence of exogenous IL-2 for 4 days, we observed the same result, Lkb1-deficient DCs could induce stronger T reg cell expansion ( Fig. 3d-f ). These results indicate that Lkb1-deficient DCs could directly promote T reg cell expansion independent of other environmental elements. We next used Transwell plates to explore whether this effect of DCs was dependent on direct cell-cell contact or soluble factors secreted from DCs; in this way, T reg cells and DCs could be physically separated but share the same medium in close proximity. Indeed, we found that enhanced T reg cell proliferation only occurred when direct contact was made with Lkb1-deficient DCs (Fig. 3g) , suggesting that Lkb1-deficient DCs promoted T reg cell proliferation in a contactdependent manner. To determine whether Lkb1-deficient DCs could induce T reg cell proliferation in vivo, we transferred DCs sorted from Lkb1 f/f or Cd11c Cre Lkb1 f/f mice together with T reg cells into irradiated NSG mice. After 3 days, we detected that 85% of the transferred cells maintained Foxp3 expression ( Supplementary Fig. 5f ), and a markedly greater absolute number of divided T reg cells was observed after co-transfer with Lkb1-deficient DCs than co-transfer with WT DCs (Fig. 3h-j) . These results indicate that Lkb1 depletion in DCs was a direct driver of T reg cell proliferation.
DC OX40L upregulation contributes to T reg cell proliferation. AMPK is a well-known downstream Lkb1 target critical for regulating metabolism 28 . To determine whether AMPK is involved in Lkb1-deficient DC function, we generated Cd11c Cre AMPKα1 f/f AMPKα2 f/f mice with the specific depletion of AMPK in DCs. However, there were no significant differences in the percentage of T reg cells or the activation of T con cells between AMPKα1 f/f AMPKα2 f/f and Cd11c Cre AMPKα1 f/ To elucidate the molecular mechanism by which Lkb1 controls DC function, we profiled the transcriptome of DCs sorted from Lkb1 f/f and Cd11c Cre Lkb1 f/f mice. We found more than 500 transcripts that were significantly (P < 0.05) up-or downregulated (1.5-fold or more) in Lkb1-deficient DCs compared with WT DCs and thus constituted the Lkb1-deficient DCspecific transcriptional signature (Supplementary Data 1). Since Lkb1-deficient DCs promoted T reg cell proliferation in a contactdependent manner, we first screened the significantly altered pathways related to cell adhesion through gene set enrichment analysis (GSEA) and noted that the gene set of cell-cell adhesion was enriched in Lkb1-deficient DCs (Fig. 4a) . Among the genes upregulated in Lkb1-deficient DCs are several that have been previously implicated in immune adhesion, including the transcripts of Ox40l (Tnfsf4) [29] [30] [31] , Cd40 32 , Fas 33 and Pdcd1 34 ( Fig. 4b, Supplementary Data 1) . The differential expression of these molecules at the mRNA and protein levels was evaluated by real-time PCR and flow cytometry, respectively. Lkb1 deficiency moderately increased the protein expression of OX40L and CD40 but barely affected that of Fas and PD1 (Fig. 4c, d and Supplementary Fig. 1c ). However, recent studies have shown that transgenic mice with constitutive CD11c-specific CD40 signalling had low T reg cell frequencies 35, 36 , suggesting that the expansion of T reg cells was unlikely due to CD40 upregulation on Lkb1-deficient DCs. We also examined the expression of OX40L on different subpopulations of DCs and found that OX40L was marginally expressed on pDCs and CD8 + cDCs from the spleen and LNs. However, the expression of OX40L on CD11b + DCs from the spleen and LNs was higher in Cd11c Cre Lkb1 f/f mice than in Lkb1 f/f mice ( Supplementary Fig. 7a , b). OX40L is a member of the TNF superfamily that has been implicated in DC-T cell interactions [29] [30] [31] . The higher expression of OX40 on T reg cells than on naive and activated CD4 + T cells ( Supplementary Fig. 8a, b) suggests that OX40L-OX40 interactions might preferentially promote T reg cell proliferation. Pre-blocking OX40L with a neutralizing antibody significantly hampered the increased proliferation and absolute number of T reg cells when co-cultured with Lkb1-deficient DCs but not when cocultured with WT DCs (Fig. 4e-g ). Since the co-stimulatory versus the -Log 10 P value (y axis, representing the probability that the gene is differentially expressed). Black dots mark genes with P > 0.1 and less than two-fold change, and tinted dots mark genes with fold changes higher than 2. Ox40l is marked. molecules CD80 and CD86 expressed on DCs have been suggested to be strong stimulators of T reg cell proliferation 37 , we took CD80 and CD86 as positive controls and found that blocking CD80 and/or CD86 on both WT and Lkb1-deficient DCs suppressed T reg proliferation ( Supplementary Fig. 9a, b) , which is consistent with the comparable expression of CD80 and CD86 on DCs from Lkb1 f/f and Cd11c Cre Lkb1 f/f mice (Supplementary Fig. 1c ). The effect of blocking OX40L on DCs from Cd11c Cre Lkb1 f/f mice was obvious, indicating that it plays a significant role in enhancing T reg cell expansion.
To confirm this result in vivo, DCs sorted from Lkb1 f/f or Cd11c Cre Lkb1 f/f mice were pre-incubated with anti-OX40L neutralizing antibody or isotype control and then transferred with CFSE-labelled T reg cells from B6 mice into irradiated NSG mice. After 3 days, we detected significantly greater proliferation and absolute cell number of T reg cells after co-transfer with Lkb1-deficient DCs than after co-transfer with WT DCs, and these increases could be mitigated by blocking OX40L (Fig. 4h-j) . These results indicate that increased OX40L expression was involved in the superior T reg cell-stimulating effect of Lkb1-deficient DCs. However, when T con cells from B6 mice were cocultured with WT and Lkb1-deficient DCs, we also observed increased T eff cell (CD44 hi CD62L low ) proliferation that could be restrained with anti-OX40L neutralizing antibody (Supplementary Fig. 10a-c) . Although Lkb1-deficient DCs have a slightly increased capacity for promoting T con cell survival compared with that of WT DCs, blocking OX40L did not have significant effect on the survival of T con cells ( Supplementary Fig. 10d, e) . This phenomenon indicates that the upregulated expression of OX40L on Lkb1-deficient DCs also contributes to the increased proportion of polyclonal T eff cells through enhancing proliferation.
Lkb1 restrains NF-κB signalling to suppress OX40L expression. We next explored the signalling pathways through which Lkb1 regulates Ox40l gene expression. Analysis of the cis-elements of the Ox40l gene revealed several conserved NF-κB binding sites (Supplementary Table 1 ). NF-κB signalling plays critical roles in regulating immune responses 38 . The NF-κB p65 transcription factor is a major component of the NF-κB family, and its phosphorylation marks the activation of the NF-κB pathway. Indeed, the level of phosphorylated NF-κB p65 was higher in Lkb1-deficient DCs than in WT DCs with or without LPS treatment (Fig. 5a and Supplementary Fig. 15a-g ). In addition, more p65 was accumulated in the nucleus of Lkb1-deficient DCs (Fig. 5b and Supplementary  Fig. 15h-j) . Surprisingly, the depletion of Lkb1 did not result in the upstream activation of IKKα/β or IκBα 38 , indicating that Lkb1 deficiency in DCs activated NF-κB signalling distinct from the canonical NF-κB signalling pathway. In addition, the NF-κB inhibitor SC75741 decreased the mRNA and protein levels of OX40L in Lkb1-deficient DCs (Fig. 5c-e) . Meanwhile, compared with untreated DCs, Lkb1-deficient DCs pre-treated with the NF-κB inhibitor showed smaller increases in the proliferation and number of T reg cells (Fig. 5f, g ). We also confirmed these results in vivo by co-transferring DCs from Lkb1 f/f and Cd11c Cre Lkb1 f/f mice pretreated with the NF-κB inhibitor with CFSE-labelled T reg cells into irradiated NSG mice (Fig. 5h, i) . Furthermore, chromatin immunoprecipitation (ChIP) assays showed more NF-κB p65 binding on the Ox40l promotor in Lkb1-deficient DCs than in WT DCs (Fig. 5j) , suggesting a direct effect of NF-κB signalling on promoting Ox40l transcription. These results suggest that an unusual form of IKKα/β-and IκBα-independent NF-κB activation drove the upregulation of Ox40l in Lkb1-deficient DCs and that this specifically activated NF-κB signalling promoted T reg cell proliferation at least partially via OX40L. 39, 40 . To investigate whether SIRT1 was involved in Lkb1-and LPS-mediated signalling in DCs, we examined the protein level of SIRT1 in Lkb1-deficient DCs and DCs from LPS-treated mice. The total protein level of SIRT1 was diminished in DCs from LPS-treated mice but not in Lkb1-deficient DCs ( Supplementary Figs. 11a and 15o, p) . Since SIRT1 negatively regulates NF-κB p65 activation 38, 39 , the downregulation of SIRT1 may contribute to the activation of NF-κB p65 in DCs from LPS-treated mice. However, SIRT1 is not reduced in Lkb1-deficient DCs, suggesting that Lkb1 loss provokes NF-κB hyperactivation independent of SIRT1. These results indicate that SIRT1 might be involved in the activation process of DCs from LPS-treated mice rather than mediating the Lkb1 effect in DCs. In addition, SIRT1 has been found to interact with the Lkb1/AMPK complex to regulate the downstream signalling 39, 41 . However, in our study, Lkb1 controlled DC function independent of AMPK. These results collectively suggest that Lkb1 function in DCs is possibly independent of SIRT1.
LPS induces T reg cell expansion via depleting Lkb1 in DCs.
The above results show the extreme enlargement of the T reg cell compartment in mice with the Lkb1 gene conditionally deleted in DCs. Considering the abundance of evidence demonstrating increased frequencies of T reg cells during certain immune responses, including those to bacterial infection [42] [43] [44] [45] , we next sought to determine whether the expression of Lkb1 would be decreased in DCs to contribute to the augmentation of T reg cells under these conditions. We intraperitoneally treated mice with LPS, a Toll-like receptor (TLR) agonist derived from gramnegative bacteria, which is capable of triggering strong immune activation. Interestingly, we found that the Lkb1 protein level was greatly reduced in DCs (Fig. 6a and Supplementary 15k, l) but not in T and B lineage cells ( Supplementary Fig. 12a and 15q-t) . Despite a significant reduction in the Lkb1 protein level in DCs, no obvious change in the Lkb1 mRNA level was observed under LPS stimulation (Fig. 6b) , suggesting that LPS might deplete Lkb1 protein via a post-transcriptional mechanism.
As expected, we observed elevated percentages and absolute numbers of T reg cells in mice under LPS stimulation (Fig. 6c, d) . The majority of these T reg cells expressed high levels of Nrp1 and Helios (Fig. 6e) , indicating that they were mostly nT reg cells. To determine the impact of the LPS-induced increase in T reg cells on the prognosis of an immune response, we pre-treated mice with or without a low dose of LPS before a lethal dose of LPS. The LPS pre-treatment protected Lkb1 f/f mice from the lethal LPS challenge, but this protective effect was significantly abolished in Lkb1 f/f Foxp3 DTR mice treated with DT (Fig. 6f) . These findings indicate the critical role of increased T reg cell populations in mediating protection against LPS-mediated inflammatory injury.
As LPS could affect the phenotype and function of multiple cell types, to confirm that the expansion of the T reg cell compartment was directly caused by DCs in LPS-treated mice, we sorted DCs from mice treated with or without LPS, incubated them with OX40L neutralizing antibody or isotype control, and co-cultured them with CFSE-labelled T reg cells for 4 days. Flow cytometry analysis showed that LPS-modified DCs promoted stronger T reg cell proliferation than did control DCs and that blocking with anti-OX40L antibody could restrain the proliferation of T reg cells in the LPS group, but not in the control group (Fig. 6g-i) . These results suggest that the T reg cell expansion in the mice was directly caused by LPS-programmed DCs and that this effect was at least partially mediated by OX40L. To evaluate whether the Lkb1 protein reduction in DCs alone would 
Lkb1 f/f +DMSO *** *** 63.5% 64.6% 79.7% 59.3% contribute to the protective effect under LPS stimulation, we administered a lethal dose of LPS to Lkb1 f/f , Cd11c Cre Lkb1 f/f and Cd11c Cre Lkb1 f/f Foxp3 DTR mice treated with DT and analysed the survival rate. The survival rate of the Cd11c Cre Lkb1 f/f mice was significantly higher than that of the other two groups of mice (Fig. 6j) , but the Cd11c Cre Lkb1 f/f Foxp3 DTR mice treated with DT, which had reduced T reg cell populations, displayed significantly reduced survival. However, there was no statistically significant difference in the survival rate between the Lkb1 f/f Foxp3 DTR and Cd11c Cre Lkb1 f/f Foxp3 DTR mice treated with DT when challenged with a lethal LPS dose (Supplementary Fig. 13a) . Thus, the LPSinduced Lkb1 depletion in DCs was directly involved in promoting T reg cell expansion to enhance immunosuppression. To further explore how Lkb1 deletion-induced T reg expansion would protect the mice from LPS toxicity, we examined the proinflammatory cytokine levels and T cell effector function of Lkb1 f/f and Cd11c Cre Lkb1 f/f mice in response to LPS. The mRNA levels of Tnf and Ifnγ were lower in the lungs of the Cd11c Cre Lkb1 f/f mice than in those of the Lkb1 f/f mice ( Supplementary Fig. 14a ). We also examined the production of Th-associated cytokines by T cells in Lkb1 f/f and Cd11c Cre Lkb1 f/f mice and found lower IFN-γ production in T cells from the lungs and spleen of Cd11c Cre Lkb1 f/f mice ( Supplementary Fig. 14b, c) .
These results indicate that the reduced production of TNF and IFN-γ in the lung tissue and the decreased numbers of IFN-γ-producing T cells might be part of the mechanisms contributing to the alleviated LPS toxicity.
E. coli induces T reg cell expansion by depleting Lkb1 in DCs.
Because LPS is a major pathogenic factor derived from gramnegative bacteria, we further tested whether infection with the gram-negative bacteria E. coli could recapitulate the effect of LPS. Consistently, the decrease in Lkb1 protein was also observed in DCs from mice with an intraperitoneal E. coli infection ( Fig. 7a and Supplementary Fig. 15m , n), along with an increased frequency and absolute number of T reg cells (Fig. 7b,  c) . These T reg cells were mostly nT reg cells given their high expression of Nrp1 and Helios (Fig. 7d ). E. coli pre-treatment protected mice from secondary lethal E. coli challenge. Surprisingly, reducing the T reg cell population with DT did not abolish the protective effect of the E. coli pre-treatment (Fig. 7e) , indicating that mechanisms other than T reg cells predominately mediated the protection from a secondary infection. As gramnegative bacteria, E. coli contain more complex virulence factors and have been shown to induce immune tolerance by multiple mechanisms 46 , which might override the protective effect of the bacteria pre-treatment-induced increase in the T reg cell population. To further determine whether Lkb1 depletion in DCs alone is sufficient to mediate tolerance to an acute primary lethal E. coli challenge, we administered lethal amounts of E. coli to Lkb1 f/f , Cd11c Cre Lkb1 f/f , and Cd11c Cre Lkb1 f/f Foxp3 DTR mice treated with DT. The Cd11c Cre Lkb1 f/f mice showed a significantly higher survival rate than the Lkb1 f/f mice upon lethal E. coli challenge, and reducing the T reg cell population in the Cd11c Cre Lkb1 f/f Foxp3 DTR mice through DT treatment resulted in poor survival (Fig. 7f) , indicating that conditional knockout of the Lkb1 gene in DCs increases the T reg cell number and the tolerance of the host to primary bacterial infections. Finally, Lkb1 f/f Foxp3 DTR and Cd11c Cre Lkb1 f/f Foxp3 DTR mice treated with DT showed comparable survival rates when challenged with a lethal dose of E. coli (Supplementary Fig. 13b ). These results indicate that the Lkb1 depletion-induced expansion of the T reg cell population promotes tolerance to primary bacterial infections but is dispensable for establishing tolerance to secondary infections.
Lkb1 discriminates regulatory from inflammatory programmes. While LPS is a well-known pathogenic factor that acts on DCs to promote inflammation, here, we show that LPS also depletes Lkb1 in DCs to induce T reg cell expansion and immunosuppression. To understand the molecular basis that differentiates the regulatory and pro-inflammatory functions, we further profiled the transcriptome of DCs sorted from mice treated with or without LPS for comparison with the aforementioned transcriptional signature of Lkb1-deficient DCs (Supplementary Data 1 and 2). GSEA showed that pathways related to inflammatory responses, inflammatory effector processes, immune responses and acute immune responses were significantly upregulated in DCs from LPS-treated mice, while no significant enrichment in these gene sets appeared in Lkb1-deficient DCs (Fig. 8a) . A substantial proportion of the upregulated transcripts in DCs from LPS-treated mice were not significantly altered in Lkb1-deficient DCs, including genes encoding the pro-inflammatory cytokines Il1α, Il27, Il15 and Il1f9, the costimulation molecule Cd80, and the chemokines Cxcl11, Cxcl9, Cxcl10 and Ccl5, which was confirmed by real-time PCR (Fig. 8b, c and Supplementary Data 2) . However, Ox40l, the upregulated transcript in Lkb1-deficient DCs, was also increased in DCs from LPS-treated mice, and real-time PCR and flow cytometry further confirmed that LPS could upregulate OX40L expression in DCs (Fig. 8d-f ). These results demonstrate that Lkb1 operated as a "regulatory switch" to discriminate the regulatory from the pro-inflammatory transcriptional programme in DCs.
Discussion
Along with tolerogenic DCs that are thought to be associated with developmental immaturity 45, 47, 48 , the concept of "regulatory DCs", which are proposed to evolve under certain immune conditions and exhibit a superior immunosuppressive capacity, has been considered for decades 10, 45 , but the underlying mechanism that governs the specification of this distinctive lineage is still elusive. In this study, we demonstrate that a deficiency in Lkb1, achieved through either artificial gene deletion or bacteria/LPS-induced protein depletion, establishes the regulatory function of DCs to augment T reg cell expansion under either steady-state or inflammatory conditions. These findings indicate a mechanism underlying this regulatory functional specification. An increasing body of evidence suggests that bacterial infection not only induces the activation of effector cells to eliminate pathogens but also elicits immunosuppression that involves iT reg cell de novo generation 1, 45, 49 . In our study, judging from the positive expression of Nrp1 and Helios, nT reg but not iT reg cells are major components of the enlarged T reg cell pool in mice intraperitoneally challenged with bacteria or LPS. We showed that bacteria and LPS pre-treatment provided protection against a lethal secondary infection. LPS pre-treatment-induced Lkb1 depletion promoted T reg expansion to protect mice from a secondary lethal challenge. However, E. coli pre-treatment-induced protection from the secondary lethal infection was largely independent of T reg expansion, indicating that other tolerance mechanisms might exist, which may override the effect of T reg cell expansion during bacterial infection. Nonetheless, functional genomic analysis revealed that the Lkb1 deficiency established a regulatory transcriptional programme in DCs without interfering with the pro-inflammatory transcriptional programme, thus providing a unique molecular basis for bacterial infectioninduced tolerance.
Despite the well-recognized role of OX40L-OX40 interactions in promoting effector T cell responses 29, 30 , the impact of OX40L-OX40 interactions on T reg cells remains controversial. Some reports have suggested that OX40 favours T reg cell suppression via increasing expansion 27, 50 , while others have demonstrated that OX40 represss T reg cell suppressive function due to T reg cell exhaustion and a lack of IL-2 31 . Our study defines the role of OX40L-OX40 interactions in promoting T reg cell proliferation driven by Lkb1-deficient DCs. Although the upregulation of OX40L on Lkb1-deficient DCs was moderate, it had a significant impact on T reg cell proliferation, as blocking OX40L on Lkb1-deficient DCs reduced T reg cell proliferation to an extent similar to that of blocking both CD80 and CD86, which are known as strong stimulators of T reg cell proliferation 37 . However, blocking OX40L on Lkb1-deficient DCs could only partially rescue the enhanced proliferation of T reg cells, suggesting that other molecules might also contribute to T reg cell proliferation. Indeed, Lkb1 also suppressed the expression of other cell membrane molecules, including semaphorins, which are involved in cell adhesion and communication 51, 52 , and CCL22, which is thought to promote T reg cell chemotaxis 53, 54 . The impact of these molecules on T reg cells within the complex immune microenvironment cannot be excluded. Therefore, we propose that Lkb1 might control a number of genes in DCs to govern the magnitude of T reg cell expansion in vivo.
We found that NF-κB p65 activation induced Ox40l expression in Lkb1-deficient DCs and that the inhibition of NF-κB signalling in Lkb1-deficient DCs reduced the proliferation of T reg cells, suggesting that NF-κB activation in Lkb1-deficient DCs promotes T reg cell proliferation at least via the upregulation of OX40L. NF-κB is a well-known mediator of TLR-triggered pro-inflammatory immune responses 38 . Therefore, it was surprising that Lkb1 deficiency-triggered p65 activation promoted the regulatory but not the pro-inflammatory function of DCs. Indeed, the conditional deletion of Lkb1 did not lead to the activation of IKKα/β or the degradation of IκBα. This unusual Lkb1 regulation of NF-κB signalling is in contrast with the results of previous studies showing that Lkb1 regulates IKKα/β activation in other immune cell types; 18, 19 thus, this might be a unique mechanism for discriminating the regulatory programme from the proinflammatory programme in DCs. In addition to OX40L, we cannot exclude the possibility that Lkb1-controlled NF-κB signalling might regulate other molecules to affect T reg cell homeostasis, which awaits future clarification.
Lkb1 also plays intrinsic roles in T reg cells. Our previous work demonstrates that Lkb1 promotes T reg cell Foxp3 expression and suppressive function 18 . In addition, Lkb1 was recently shown to programme T reg cell metabolic and functional fitness 55 . Intriguingly, here, we show that Lkb1 operates in DCs to negatively regulate T reg cell expansion and immunosuppression. Furthermore, LPS treatment selectively depleted Lkb1 in DCs but not in T reg cells to potentiate immunosuppression. Surprisingly, the conditional deletion of Lkb1 in monocytes/macrophages, which share certain functions (e.g., antigen presentation, inflammatory mediator production) with DCs, did not lead to T reg cell expansion. Together, these results highlight an environment-and cell type-conditioned function of Lkb1 in the orchestration of immunity versus tolerance.
In conclusion, these findings indicate that the abundance and immunosuppression strength of T reg cells are dynamically governed, in both a feedforward and feedback manner, by the Lkb1 "regulatory switch" in DCs to maintain immune equilibrium. Our study also revises the concept of "regulatory DCs" by providing evidence supporting a unifying model of regulatory and inflammatory programmes that can co-evolve but are separately instructed by different signals in the same DCs during maturation/activation. These findings provide insight into the sophisticated DC-T reg cell interactions that are fundamental for controlling immune equilibrium. Given that dysregulated T reg cell pools are involved in the pathogenesis of various cancerous and autoimmune diseases, our work may provide therapeutic targets for the clinical treatment of these T reg cell-related immune diseases.
Methods
Mice. All animals were maintained in specific pathogen-free barrier facilities and used in accordance with protocols approved by the Institutional Animal Care and User Committee at the Institute of Hematology, Chinese Academy of Medical Sciences. C57BL/6, Lkb1 f/f , AMPKα1 f/f , AMPKα2 f/f , Cd11c Cre , Foxp3 YFP-Cre , LysM Cre , Foxp3 DTR and NOD/scid IL2Rg null (NSG) mice were purchased from Jackson Laboratories. All mice had been backcrossed with C57BL/6 mice for at least seven generations. Lkb1 f/f , AMPKα1 f/f and AMPKα2 f/f mice were crossed with Cd11c Cre , LysM Cre to generate Cd11c Cre Lkb1 f/f , Cd11c Cre AMPKα1 f/f AMPKα2 f/f , and LysM Cre Lkb1 f/f mice, respectively. Cd11c Cre Lkb1 f/f mice were crossed with Foxp3 DTR mice to generate Cd11c Cre Lkb1 f/f Foxp3 DTR mice. All mice were used when 6-8 weeks old unless otherwise noted. The sample size was selected to maximize the chance of uncovering a mean difference with statistical significance. No statistical methods were used to predetermine the sample size. The experiments were not randomized, and the investigators were not blinded to group allocation during the experiments or outcome assessments. Apoptosis detection. Annexin V and PI staining was performed using an apoptosis detection kit (Biolegend) according to the manufacturer's instruction to determine the apoptosis of T reg cells in the spleen from Lkb1 f/f and Cd11c Cre Lkb1 f/f mice.
T cell proliferation and activation. CD4 + and CD8 + T cells were sorted from OT-II and OT-I transgenic mice, labelled with CFSE, and then co-cultured with Cd11c Cre Lkb1 f/f and Lkb1 f/f DCs loaded with the respective antigen peptide (OVA 323-339 and OVA 257-264 , Sigma-Aldrich) for 4 days. For the in vivo study, Lkb1 f/f , Cd11c Cre Lkb1 f/f and Cd11c Cre Lkb1 f/f Foxp3 DTR mice treated were with diphtheria toxin (DT) for 2 days; then, CFSE-labelled CD4 + T cells were transferred into these mice via tail vein injection. After 1 day, the mice were challenged by a subcutaneous injection of 20μg of OVA protein (A5503, Sigma-Aldrich) with 100 μl of Complete Freund's adjuvant (CFA). In addition, 3 days later, the LNs were removed and the cell populations were analysed by flow cytometry.
Immunoblot analysis. DCs were sorted from Lkb1 f/f and Cd11c Cre Lkb1 f/f mice and treated as indicated, and then the cells were lysed with RIPA buffer or nuclear/ cytosol fractionation reagent (Bio Vision) supplemented with protease and phosphatase inhibitors. The protein concentration in the extract was measured by BCA assay. The same amount of protein for each sample was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred by electroblotting and membranes blocked in 5% milk/Tris buffered saline with Tween 20 (TBS-T) for 1 h. Membranes were incubated with appropriate antibodies overnight at 4°C, then exposed to secondary antibodies for 2 h at room temperature and developed using ECL Western Blotting Substrate. Western blot was carried out with antibodies against Lkb1 (1:500), phospho-IKKα/β (Ser176/180, 1:500), phospho-IκBα (Ser32, 1:500), phospho-NF-κB p65 (Ser536, 1:500), IKKα (1:500), IκBα (1:500), NF-κB p65 (1:500) and GAPDH (1:1000). These antibodies were purchased from Cell signalling Technology, USA. Uncropped scans of all the blots were provided in the Supplementary Figure 15 .
Microarray and quantitative real-time PCR. DCs were sorted from the spleen of Lkb1 f/f mice, LPS-treated mice, and Cd11c Cre Lkb1 f/f mice for RNA extraction with TRIzol reagent (Invitrogen). Total RNA was reverse-transcribed, amplified, labelled, and hybridized to Mouse Genome 2.0 arrays (Affymetrix). The microarray data sets were analysed using Agilent GeneSpring GS 11 software and GSEA. RNA from different samples was obtained in the same manner as for the microarray analysis, and real-time PCR was performed with SYBR Green PCR Master Mix (ABI). The sequences of the primer pairs used are listed in Supplementary Table 2 .
ELISA. The concentrations of IgG in the serum of Lkb1 f/f and Cd11c Cre Lkb1 f/f mice were determined by sandwich ELISA (Biolegend), according to the manufacturer's instructions.
Chromatin immunoprecipitation (ChIP). ChIP assays were performed using ChIP kits (Active Motif) according to the manufacturer's protocols. Precipitated DNA and input DNA were assessed by real-time PCR using the primers listed in Supplementary Table 2 . Injection of LPS and bacteria. LPS (Sigma-Aldrich) or E. coli provided by Prof. Yuanfu Xu (Chinese Academy of Medical Sciences) in 200 μl of PBS was administered by tail vein or intraperitoneal injection. Bacteria were stored in 20% glycerol at −80°C. For expansion, bacteria were cultured on LB agar through plated streaking overnight. One colony of bacteria was selected, suspended in 4 ml of LB and incubated for 12 h (200 revolutions/min, 37°C). The suspension was then centrifuged at 8000 rpm for 5 min. The pellet was washed twice with PBS and then resuspended in PBS. The determined concentration of the suspension was adjusted to the desired dose using PBS.
Statistics. An unpaired two-tailed Student's t-test (for the comparison of two groups) or two-way ANOVA (for the comparison of more than two groups) were performed using Prism (GraphPad) to calculate the statistical significance of differences in the mean values as indicated by the P value. P values < 0.05 were considered statistically significant. *P < 0.05; **P < 0.01; ***P < 0.001.
Data availability
The data that support the findings of this study are available from the corresponding author on reasonable request. The microarray data that support the findings of this study have been deposited in the Gene Expression Omnibus under accession number GSE117286. A reporting summary for this Article is available as a Supplementary Information file.
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